Amneal Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Amneal Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 28 Products, $106.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Amneal Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 28 Products, $106.5M Trade | TransData Nexus

Amneal Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $106.5M Total Trade · DGFT Verified

Amneal Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $106.5M across 28 products in 19 therapeutic categories. Based on 2,360 verified export shipments from Indian Customs (DGFT) records, Amneal Pharmaceuticals Private Limited is the #1 Indian exporter in 2 products including Warfarin, Niacin. Top exports include Iron ($18.8M), Spironolactone ($18.6M), Gabapentin ($15.2M).

Amneal Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Amneal Pharmaceuticals Private Limited pharmaceutical export portfolio — 28 products across 19 therapeutic categories. Source: Indian Customs (DGFT).

Who is Amneal Pharmaceuticals Private Limited? — Company Overview & Market Position

Amneal Pharmaceuticals Private Limited, incorporated on April 7, 2006, is a private limited company based in Ahmedabad, Gujarat, India. The company's Corporate Identification Number (CIN) is U24231GJ2006PTC048109. As of January 6, 2026, Amneal Pharmaceuticals Private Limited has an authorized capital of ₹640.00 crore and a paid-up capital of ₹362.77 crore. The registered office is located at 901-911, Iscon Elegance, Opp. Karnavati Club, S.G. Highway, Ahmedabad, Gujarat, 380015.

The company is a subsidiary of Amneal Pharmaceuticals, Inc., a global biopharmaceutical company headquartered in Bridgewater, New Jersey, USA. Amneal Pharmaceuticals, Inc. is publicly traded on the NASDAQ under the ticker symbol AMRX. The company has a diversified portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States.

What Does Amneal Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Iron$18.8M 2Spironolactone

Product Portfolio — Top 28 by Export Value

Amneal Pharmaceuticals Private Limited exports 28 pharmaceutical products across 19 therapeutic categories. Market leader (#1 exporter) in 2 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Iron	Vitamins & Supplements	$18.8M	375	3.8%	3
2	Spironolactone	Diuretics	$18.6M	373	9.4%	2
3	Gabapentin	CNS & Psychiatric	$15.2M	304	1.8%	6
4	Potassium	Nutritional Supplements	$9.2M	184	1.4%	14
5	Naproxen	Analgesics & Antipyretics	$6.0M	119	4.4%	4
6	Ras	Ayurvedic & Herbal Products	$4.5M	91	1.5%	13
7	Pantoprazole	Gastrointestinal	$4.2M	87	0.3%	13
8	Tramadol	Analgesics & Antipyretics	$4.2M	83	1.1%	5
9	Fenofibrate	Lipid & Metabolism	$3.1M	62	4.2%	9
10	Magnesium	Vitamins & Supplements	$3.1M	78	0.9%	12
11	Azathioprine	Immunosuppressants	$3.0M	60	8.9%	3
12	Warfarin	Cardiovascular	$2.9M	242	38.6%	1
13	Oseltamivir	Antivirals	$2.8M	56	2.3%	7
14	Itraconazole	Antifungals	$1.9M	38	6.9%	6
15	Ezetimibe	Lipid & Metabolism	$1.5M	30	0.3%	15
16	Niacin	Lipid & Metabolism	$1.4M	36	36.5%	1
17	Prednisone	Respiratory	$1.4M	27	4.8%	4
18	Doxycycline	Antibiotics	$1.1M	23	1.0%	5
19	Chloroquine	Antimalarial & Antiparasitic	$950.0K	19	0.6%	7
20	Carvedilol	Cardiovascular	$812.6K	24	0.8%	15
21	Propranolol	Cardiovascular	$400.0K	8	0.7%	6
22	Methylprednisolone	Corticosteroids	$336.0K	7	1.1%	13
23	Griseofulvin	Advanced Antifungals	$318.5K	15	0.9%	11
24	Sulfamethoxazole	Advanced Antibiotics	$250.0K	5	1.3%	5
25	Trimethoprim	Advanced Antibiotics	$250.0K	5	0.9%	7
26	Fosfomycin	Advanced Antibiotics	$150.0K	3	1.2%	4
27	Fulvestrant	Advanced Oncology	$150.0K	3	1.0%	11
28	Hydroxychloroquine	Antimalarial & Antiparasitic	$150.0K	3	0.1%	7

Amneal Pharmaceuticals Private Limited exports 28 pharmaceutical products across 19 therapeutic categories with a total export value of $106.5M. The company is the #1 Indian exporter in 2 products: Warfarin, Niacin. The top category is Vitamins & Supplements (20.5% of portfolio), followed by Diuretics (17.5%), indicating a concentrated portfolio with the top 5 products accounting for 63.6% of total export value.

Amneal Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Amneal Pharmaceuticals Private Limited operates multiple manufacturing facilities in India, strategically located to serve both domestic and international markets. The company has invested significantly in these facilities, with a total investment of $500 million as of 2023. The most recent facility, established in 2022, focuses on the production of injectable medications. These facilities adhere to current Good Manufacturing Practices (cGMP) and comply with regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO).

3Key Leadership

Amneal Pharmaceuticals Private Limited is led by a team of experienced professionals committed to the company's mission of providing high-quality, affordable medicines. The board of directors includes Kanubhai Punambhai Patel, Suresh Punambhai Patel, and Pankil Narendra Kumar Patel. The company's leadership is guided by the principles of honesty and integrity, inspired by the founders' father, Kanu Patel, an industrial pharmacist and pharmaceutical regulatory inspector in India.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Amneal Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Amneal Pharmaceuticals Private Limited has established a significant presence in regulated markets, particularly in the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained approvals for various pharmaceutical products from regulatory bodies such as the FDA, EMA, and the Medicines and Healthcare products Regulatory Agency (MHRA). These approvals enable Amneal to market and distribute its products in these regions, ensuring compliance with stringent quality and safety standards. The company's adherence to Good Manufacturing Practices (GMP) and other regulatory requirements facilitates its market access and competitiveness in these regions.

2Emerging Markets

Amneal Pharmaceuticals Private Limited is actively expanding its footprint in emerging markets, including Africa, Latin America, and Southeast Asia. The company's commitment to quality is demonstrated by its adherence to WHO prequalification standards, which is essential for accessing these markets. By obtaining WHO prequalification, Amneal ensures that its products meet international quality standards, facilitating smoother entry and acceptance in these regions. This strategic approach positions Amneal to address the growing demand for affordable and high-quality medicines in emerging markets.

Geographic Strategy

Amneal Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Amneal Pharmaceuticals Private Limited's parent company, Amneal Pharmaceuticals, Inc., has a robust relationship with the U.S. Food and Drug Administration (FDA). The company has multiple FDA facility registrations, reflecting its compliance with U.S. regulatory standards. Amneal has received approvals for Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs), indicating its capability to produce generic drugs and active pharmaceutical ingredients for the U.S. market. The company's facilities have undergone FDA inspections, demonstrating adherence to current Good Manufacturing Practices (cGMP). This regulatory compliance underscores Amneal's commitment to delivering safe and effective pharmaceutical products.

2WHO & EU GMP

Amneal Pharmaceuticals Private Limited's manufacturing facilities comply with Good Manufacturing Practices (GMP) standards set by the World Health Organization (WHO) and the European Union (EU). This compliance ensures that the company's products meet international quality standards, facilitating market access in regions that require WHO and EU GMP certification. The company's adherence to these standards reflects its commitment to producing high-quality pharmaceutical products for global markets.

CDSCO & Indian Regulatory

Amneal Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Amneal Pharmaceuticals Private Limited operates in a competitive landscape, with several key players in the pharmaceutical industry. The company's top five exported products—Iron, Spironolactone, Gabapentin, Potassium, and Naproxen—account for a significant portion of its export value. In the Indian market, Amneal faces competition from other pharmaceutical manufacturers offering similar products. The company's adherence to international quality standards, such as WHO prequalification and EU GMP certification, provides a competitive edge in both domestic and international markets. By maintaining high manufacturing standards and a diverse product portfolio, Amneal positions itself as a strong competitor in the pharmaceutical industry.

2Key Differentiators

Amneal Pharmaceuticals Private Limited distinguishes itself through its commitment to quality, regulatory compliance, and a diversified product portfolio. The company's adherence to WHO prequalification and EU GMP standards ensures that its products meet international quality benchmarks, facilitating market access in various regions. Additionally, Amneal's focus on complex dosage forms, including injectables and biosimilars, demonstrates its capability to address a broad range of therapeutic areas. These differentiators enable Amneal to meet the evolving needs of patients and healthcare providers globally.

Strategic Position

Buyer Due Diligence Brief — Evaluating Amneal Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Amneal Pharmaceuticals Private Limited has demonstrated a strong track record in pharmaceutical manufacturing, with a total export value of $106.5 million USD and 2,360 shipments across 28 products in 19 therapeutic categories. The company's top five products—Iron, Spironolactone, Gabapentin, Potassium, and Naproxen—account for 63.6% of its export value, indicating a focused product portfolio. Amneal's adherence to international quality standards, such as WHO prequalification and EU GMP certification, underscores its reliability as a supplier. The company's consistent export performance and commitment to quality make it a dependable partner for pharmaceutical distribution.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Amneal Pharmaceuticals Private Limited

How many pharmaceutical products does Amneal Pharmaceuticals Private Limited export from India?

Amneal Pharmaceuticals Private Limited exports 28 pharmaceutical products across 19 therapeutic categories. The top exports are Iron ($18.8M), Spironolactone ($18.6M), Gabapentin ($15.2M), Potassium ($9.2M), Naproxen ($6.0M). Total export value is $106.5M.

What is Amneal Pharmaceuticals Private Limited's total pharmaceutical export value?

Amneal Pharmaceuticals Private Limited's total pharmaceutical export value is $106.5M, based on 2,360 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Amneal Pharmaceuticals Private Limited the #1 Indian exporter?

Amneal Pharmaceuticals Private Limited is the #1 Indian exporter in 2 products: Warfarin (38.6% market share), Niacin (36.5% market share).

What therapeutic categories does Amneal Pharmaceuticals Private Limited cover?

Amneal Pharmaceuticals Private Limited exports across 19 therapeutic categories. The largest are Vitamins & Supplements (20.5%, 2 products), Diuretics (17.5%, 1 products), CNS & Psychiatric (14.3%, 1 products).

Get Full Amneal Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.